Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scadding, G. K.
Right arrow Articles by Havard, C. W.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scadding, G. K.
Right arrow Articles by Havard, C. W.H.
NEUROLOGY 1979;29:502
© 1979 American Academy of Neurology

Humoral immunity before and after thymectomy in myasthenia gravis

Glenis K. Scadding, M.R.C.P., A.D.B. Webster, M.R.C.P., M. Ross, M.S.C. M.I. Biol., H. C. Thomas, M.R.C.P. and C. W.H. Havard, F.R.C.P.

Royal Free Hospital, London, and the Immune Deficiency Referral Laboratory, Clinical Research Centre, Northwick Park, Great Britain.

Humoral immunity was studied in 10 patients with myasthenia gravis before thymectomy, in 15 different patients over 10 years after thymectomy, and in normal controls. Antibody titers to acetylcholine receptor were significantly (p < 0.01) lower in the post-thymectomy group. However, other antibody titers to common viruses, and to Escherichia coli, and isohemagglutinins showed no significant change. Levels of IgM and IgE (with atopic subjects excluded) decreased following thymectomy (p < 0.05). Autoantibodies persisted, apart from those directed against the acetylcholine receptor. The absence of any significant changes in humoral immunity after thymectomy for myasthenia gravis suggests that there is no generalized loss of helper T-cell function.

Dr. Scadding's address is Department of Endocrinology, Royal Free Hospital, London, Great Britain.

Accepted for publication August 10, 1978.




This article has been cited by other articles:


Home page
JAMAHome page
M. E. Seybold
Myasthenia Gravis: A Clinical and Basic Science Review
JAMA, November 11, 1983; 250(18): 2516 - 2521.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
W. Alt and H. I. Hochman
Thyrotoxicosis and Myasthenia Gravis: Case Reports and Discussion of Immunologic Similarities
Clinical Pediatrics, December 1, 1982; 21(12): 749 - 752.
[PDF]


Home page
Arch NeurolHome page
J. Keesey, F. Naiem, J. Lindstrom, D. Roe, C. Herrmann Jr, and R. Walford
Acetylcholine Receptor Antibody Titer and HLA-B8 Antigen in Myasthenia Gravis
Arch Neurol, February 1, 1982; 39(2): 73 - 77.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by AAN Enterprises, Inc.